Mylan’s Chief Is Chastised by Lawmakers Questioning EpiPen Pricing

September 22, 2016 12:18 AM

2 0

Mylan’s Chief Is Chastised by Lawmakers Questioning EpiPen Pricing

Members of Congress on Wednesday pelted the chief executive of Mylan, the company behind the EpiPen, the treatment for severe allergy attacks, with questions about steep price increases on the product and accused her of turning her back on families that could no longer afford the lifesaving treatment.

The chief executive, Heather Bresch, was the latest in a string of drug company leaders to be interrogated by the House Committee on Oversight and Government Reform as public outrage has grown over the rising cost of drugs.

Also read: SoftBank Chief’s Meeting With Donald Trump Fuels Hopes of Telecom Megadeal

Read more

To category page

Loading...